0001209191-18-025436.txt : 20180418
0001209191-18-025436.hdr.sgml : 20180418
20180418173125
ACCESSION NUMBER: 0001209191-18-025436
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20180416
FILED AS OF DATE: 20180418
DATE AS OF CHANGE: 20180418
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: SPECTOR STEVEN W
CENTRAL INDEX KEY: 0001170362
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-31161
FILM NUMBER: 18761950
MAIL ADDRESS:
STREET 1: ARENA PHARMACEUTICALS INC
STREET 2: 6166 NANCY RIDGE DRIVE
CITY: SAN DIEGO
STATE: CA
ZIP: 92121
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: ARENA PHARMACEUTICALS INC
CENTRAL INDEX KEY: 0001080709
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 232908305
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 6154 NANCY RIDGE DRIVE
CITY: SAN DIEGO
STATE: CA
ZIP: 92121
BUSINESS PHONE: 858-453-7200
MAIL ADDRESS:
STREET 1: 6154 NANCY RIDGE DRIVE
CITY: SAN DIEGO
STATE: CA
ZIP: 92121
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2018-04-16
0
0001080709
ARENA PHARMACEUTICALS INC
ARNA
0001170362
SPECTOR STEVEN W
C/O ARENA PHARMACEUTICALS, INC.
6154 NANCY RIDGE DRIVE
SAN DIEGO
CA
92121
0
1
0
0
EVP, General Counsel & Sec
Common Stock
2018-04-16
4
M
0
15001
17.90
A
34691
D
Common Stock
2018-04-16
4
M
0
15000
18.10
A
49691
D
Common Stock
2018-04-16
4
S
0
20901
34.3264
D
28790
D
Common Stock
2018-04-16
4
S
0
7700
34.9957
D
21090
D
Common Stock
2018-04-16
4
S
0
1400
35.8107
D
19690
D
Employee Stock Option (right to buy)
17.90
2018-04-16
4
M
0
15001
0.00
D
2022-12-15
Common Stock
15001
14999
D
Employee Stock Option (right to buy)
18.10
2018-04-16
4
M
0
15000
0.00
D
2022-03-19
Common Stock
15000
34530
D
The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan established by the reporting person.
The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $33.77 to $34.76, inclusive. The reporting person undertakes to provide Arena Pharmaceuticals, Inc., any security holder of Arena Pharmaceuticals, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes 2, 3 and 4 to this Form 4.
The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $34.77 to $35.63, inclusive.
The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $35.80 to $35.84, inclusive.
The options vest in four equal annual installments and are exercisable once vested. The first and second installments became exercisable on December 15, 2016 and 2017, and the third and fourth installments vest on December 15, 2018 and 2019.
The options vested in four equal annual installments on March 19, 2013, 2014, 2015 and 2016, and were immediately exercisable once vested.
Steven W. Spector
2018-04-18